Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study.

  • Damir Erkapic
  • Johannes Sperzel
  • Sascha Stiller
  • Ulf Meltendorf
  • Johann Mermi
  • Karl Wegscheider
  • Burkhard Hügl
  • INSURE Investigators

Abstract

Prevention of sudden cardiac death by means of the implantable cardioverter/defibrillator (ICD) is considered to be a lifelong therapy. However, it is still unresolved if patients who never experienced an appropriate ICD intervention during generator longevity really need to undergo device replacement.

Bibliographical data

Original languageEnglish
Article number2
ISSN0195-668X
Publication statusPublished - 2013
pubmed 22771679